Introducing the Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322) – the revolutionary biotech product designed to enhance your research and experiments.
Biological Function:
Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322) is a single domain antibody that specifically targets and binds to the beta-2-microglobulin (B2M) protein. B2M is a small protein found on the surface of most cells and is involved in immune system regulation and cell signaling. By targeting and binding to B2M, this VHH antibody can effectively block its function and provide valuable insights into its role in various biological processes.
Main Applications:
This powerful VHH antibody has a wide range of applications in the field of biotechnology. It can be used in research studies to investigate the role of B2M in immune system disorders, cancer, and other diseases. Additionally, it can be used in diagnostic assays to detect and measure B2M levels in biological samples. Its high specificity and sensitivity make it a valuable tool for various applications in the biotech industry.
Experimental Use Cases:
The Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322) has been extensively tested in various experimental settings, with promising results. In one study, it was used to inhibit B2M-mediated immune suppression in cancer cells, leading to enhanced anti-tumor immune response. In another study, it was used in a diagnostic assay to detect B2M levels in patients with chronic kidney disease, providing valuable insights into disease progression.
With its versatile applications and proven efficacy, the Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322) is a must-have for any biotech research laboratory.
Unleash the Full Potential of Your Research with Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322)
Targeting and Inhibiting B2M for Enhanced Insights
By specifically targeting and binding to the B2M protein, this VHH antibody can effectively block its function and provide valuable insights into its role in various biological processes.
Wide Range of Applications in Biotechnology
Utilize this powerful VHH antibody in research studies to investigate immune system disorders, cancer, and other diseases, or in diagnostic assays to detect and measure B2M levels in biological samples.
Proven Efficacy in Experimental Settings
Extensively tested, the Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322) has shown promising results in inhibiting B2M-mediated immune suppression in cancer cells and detecting B2M levels in patients with chronic kidney disease.
Upgrade Your Biotech Research with Anti-Human B2M/Beta-2-microglobulin VHH (SAA2322)
There are no reviews yet.